ANRO (Alto Neuroscience) Total Liabilities : $26.08 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Alto Neuroscience Total Liabilities?

Alto Neuroscience's Total Liabilities for the quarter that ended in Dec. 2024 was $26.08 Mil.

Alto Neuroscience's quarterly Total Liabilities increased from Jun. 2024 ($17.58 Mil) to Sep. 2024 ($26.56 Mil) but then declined from Sep. 2024 ($26.56 Mil) to Dec. 2024 ($26.08 Mil).

Alto Neuroscience's annual Total Liabilities increased from Dec. 2022 ($89.26 Mil) to Dec. 2023 ($158.30 Mil) but then declined from Dec. 2023 ($158.30 Mil) to Dec. 2024 ($26.08 Mil).

Alto Neuroscience Total Liabilities Historical Data

The historical data trend for Alto Neuroscience's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alto Neuroscience Total Liabilities Chart

Alto Neuroscience Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Total Liabilities

41.27

89.26

158.30

26.08

Alto Neuroscience Quarterly Data
	Dec21	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial					158.30	16.82	17.58	26.56	26.08

Alto Neuroscience Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Alto Neuroscience's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	10.008	+	(16.074	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	26.08

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	177.542	-	151.46
	=	26.08

Alto Neuroscience's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	10.008	+	(16.074	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	26.08

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	177.542	-	151.46
	=	26.08

Alto Neuroscience Total Liabilities Related Terms

Thank you for viewing the detailed overview of Alto Neuroscience's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Alto Neuroscience Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

369 South San Antonio Road, Los Altos, CA, USA, 94022

Website

https://www.altoneuroscience.com

Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.